ORM2 and arthritic joint disease: Moreover, compared with vehicle injection, intra-articular injection of ORM2 markedly exacerbated the suboptimal severity of IL-1β-induced arthritis, as assessed by inflammatory cell infiltration and synovial hyperplasia (Fig. 7b).